You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Comparison of PET/CT and PET/MR Imaging in Oncology

Version: 2 ID: ES PET 16 avr 2024
Type of Content: Guidelines & Advice, Clinical, Evidence Summary
Document Status: Current
Authors:
A. Singnurkar, R. Poon, U. Metser

Objective

To evaluate the comparability of diagnostic performance between PET/CT and PET/MR imaging in patients with oncologic diseases.

Patient Population

Patients with suspected or diagnosed cancers.

Intended Guideline Users

This evidence summary is intended to guide the Ontario PET Steering Committee in their decision-making with respect to expanding the use of PET/MRI for approved indications. This document may also be useful to inform clinicians who are seeking information about the clinical value of PET/MRI for oncologic applications. 

Research Question(s)

Is the accuracy of the PET data obtained with PET/MRI comparable to that of PET/CT, regarding the diagnosis and staging, assessment of treatment response, detection and restaging of recurrence, or evaluation of metastasis?

pdf download Summary (PDF) (3.53 Mo)